65 results
PRE 14C
z02j03anffdchw04r
16 Dec 22
Preliminary information
4:31pm
8-K
EX-10.1
gc50vssurdoxijyvw
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.2
rr3n24w9b90h1 4k
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
0eoguv2wxad1
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
D
mnvrpmaiha033
31 Aug 22
$5M in debt
2:58pm
8-K
EX-10.1
etkuv1mwu l7
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm